Clinical Trial Update: ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML) [Phase 3]

View source ↗

Summary

The ALFA-0703 Phase 3 trial in older patients with acute myeloid leukemia has been withdrawn from the program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Acute Leukemia French Association | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: WITHDRAWN